Standard BioTools Inc.
LABNASDAQHealthcare● Active
$0.80
$-0.35(-30.16%)
Market Cap$313543667
P/E Ratio—
52W High$1.72
52W Low$0.7953
Standard BioTools Inc.（LAB）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LAB · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($74.90M) | ($138.88M) | ($74.66M) | ($190.10M) | ($59.24M) |
| Depreciation & Amort. | $1.72M | $16.86M | $15.18M | $15.03M | $16.20M |
| Stock-Based Comp. | $29.61M | $31.73M | $13.12M | $14.88M | $16.10M |
| Change in Working Capital | ($44.98M) | ($12.08M) | $1.79M | ($12.35M) | ($18.01M) |
| Net Cash from Operations | ($74.35M) | ($143.45M) | ($43.29M) | ($89.37M) | ($44.06M) |
| Investing Activities | |||||
| Capital Expenditure | ($8.30M) | ($8.36M) | ($2.83M) | ($3.83M) | ($13.26M) |
| Purchases of Investments | ($140.93M) | $0.00M | ($94.90M) | $0.00M | $0.00M |
| Sales of Investments | $179.00M | $0.00M | $117.96M | $0.00M | $0.00M |
| Net Cash from Investing | $24.77M | $363.17M | $20.24M | ($88.13M) | ($11.95M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | ($40.95M) | ($5.41M) | ($0.77M) | ($1.79M) |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | ($63.19M) | ($2.08M) | $18.16M | $9.50M |
| Net Cash from Financing | $0.57M | ($102.62M) | ($6.81M) | $230.76M | $15.96M |
| Free Cash Flow | |||||
| Free Cash Flow | ($82.65M) | ($151.81M) | ($46.12M) | ($93.19M) | ($57.33M) |
| FCF Margin %(computed) | -96.86% | -87.03% | -43.37% | -95.15% | -43.90% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Standard BioTools Inc.
关于Standard BioTools Inc.（LAB）现金流量表
Standard BioTools Inc. 2025财年经营活动现金流($0.07B)，自由现金流($0.08B)（FCF利润率-96.86%），资本支出($0.01B)。
常见问题
LAB · 4 问Standard BioTools Inc. 2025财年自由现金流($0.08B)，同比up45.6%。
LAB free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10